Results 171 to 180 of about 65,782,767 (266)

Gut Microbiota in Heart Failure with Preserved Ejection Fraction: Clinical Phenotyping and Therapeutic Opportunities. [PDF]

Biomedicines
Loncar G, Bojic M, Repac J, Cvetinovic N, Rakic M, Nedeljkovic T, Lunic T, Obradovic D, von Haehling S, Lainscak M, Otasevic P, Petrovic M, Blagojevic N, Vukasinovic D, Bozic B, Bozic Nedeljkovic B.   +15 more
europepmc   +1 more source

Comprehensive exploration of unexplained dyspnoea in subjects with normal ejection fraction and low natriuretic peptides

ESC Heart Failure, Volume 12, Issue 2, Page 879-887, April 2025.
Abstract Background Unexplained exertional dyspnoea without significant elevation of natriuretic peptides is common. One of the causes might be early heart failure with preserved ejection fraction (HFpEF). Aims This study aimed to characterize patients with exertional dyspnoea and normal/near‐to‐normal N‐terminal pro‐brain natriuretic peptide (NT ...
Emmanuelle Berthelot, Tarek Laouar, Antoine Beurnier, Nataliya Hrynchynshyn, Jean Christophe Eicher, Jean‐Michel Tartière, Patrick Jourdain, Olivier Lairez, Barnabas Gellen   +8 more
wiley   +1 more source

Macrophage-Dependent Intercellular Crosstalk in Multiphenotypic Heart Failure With Preserved Ejection Fraction. [PDF]

J Am Heart Assoc
Huang Y, Luo L, Ma X, Huang Y, Zhang C, Hao X, Zhang L, Zhu H, Dai L, Liu M.   +9 more
europepmc   +1 more source

Growth differentiation factor‐15 and N‐terminal pro‐BNP in acute heart failure with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 888-899, April 2025.
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) continues to be an increasingly common health problem associated with a high mortality rate. Elevated levels of Growth differentiation factor‐15 (GDF15) and N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) are reportedly associated with poor clinical outcomes in a broad range of ...
Yoichiro Otaki, Tetsu Watanabe, Mari Shimizu, Shingo Tachibana, Junya Sato, Yuta Kobayashi, Harutoshi Tamura, Shigehiko Kato, Satoshi Nishiyama, Hiroki Takahashi, Takanori Arimoto, Masafumi Watanabe   +11 more
wiley   +1 more source

Systemic inflammation and the risk of adverse clinical outcomes in heart failure with preserved ejection fraction. [PDF]

Front Cardiovasc Med
Nguyen C, Zhang G, Iyer P, Ackermann A, Skaar JR, Chow W, Ryali R, Harrington J.   +7 more
europepmc   +1 more source

The role of cardiac acoustic biomarkers in monitoring patients with heart failure: A systematic literature review

ESC Heart Failure, Volume 12, Issue 2, Page 980-997, April 2025.
Abstract Heart failure (HF) creates a considerable clinical, humanistic and economic burden on patients and caregivers as well as on healthcare systems. To attenuate the significant burden of HF, there is a need for enhanced management of patients with HF.
Javed Butler, Malcolm Brown, Philippe Prokocimer, Ashley C. Humphries, Sophie Pope, Olivia Wright, Jun Su, Osama Elnawasany, Bogdan Muresan   +8 more
wiley   +1 more source

Risk prediction in patients with heart failure with preserved ejection fraction: the LIFE-Preserved model. [PDF]

Eur Heart J
Reitsma TH, Savarese G, Kuźma Ł, Deo SV, Pennells L, Hageman SHJ, Holtrop J, Benson L, Conrad N, Lund LH, Kurasz A, Kaptoge S, Keene SJ, Chilala C, Pitt M, Fletcher RA, Khunti K, Piepoli M, Rossello X, Lees JS, Kavousi M, McEvoy JW, Wood AM, de Boer RA, Andersson C, Visseren FLJ, Koudstaal S, Di Angelantonio E, Dorresteijn JAN, CVD-COVID-UK/COVID-IMPACT Consortium , ESC Cardiovascular Risk Collaboration.   +30 more
europepmc   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

Mitochondrial heterogeneity across cardiac cell types in heart failure with preserved ejection fraction. [PDF]

Redox Biol
Sinha A, Kolmetzky D, Tomar D, Jadiya P.
europepmc   +1 more source

Molecular Pathways, Target Landscape, and Translational Models in Heart Failure with Preserved Ejection Fraction. [PDF]

Cells
Qamar H, Saini JS, Figarska SM, Buys ES, Wagh V.   +4 more
europepmc   +1 more source